The starting material is the product of a chemical strategy the same group pioneered in 2023. Rather than introducing transcription factors or relying on rare, transient subpopulations of embryonic stem cells, the team used a defined cocktail of small molecules to push mouse cells into a state that molecularly mirrors the two-cell embryo, the earliest stage at which the zygotic genome has just switched on. Single-cell RNA sequencing of the resulting ciTotiSCs revealed strong activation of both maternal and zygotic genome activation programs, hallmarks of genuine totipotency, alongside suppression of the pluripotency networks that define conventional embryonic stem cells. In other words, the cells were not merely pluripotent, capable of making embryonic tissues, but appeared to carry the broader potential that includes the extraembryonic lineages needed to build a placenta and yolk sac.

Converting that molecular resemblance into actual embryogenesis, however, demanded a carefully choreographed culture environment. The researchers aggregated ciTotiSCs in microwells and exposed them to a sequence of media conditions, including combinations of small molecules and growth factors such as A83-01, CHIR, LPA, EGF and BMP4, followed by heparin and FGF4. Within days, the aggregates formed blastocyst-like structures that closely resembled natural blastocysts in both morphology and lineage segregation. Immunostaining showed the expected spatial organization: SOX2- and OCT4-positive cells forming the inner cell mass, GATA3-positive cells forming the trophectoderm, and GATA6- and SOX17-positive cells marking the primitive endoderm. Even the squamous, stretched morphology of natural trophectoderm cells was reproduced, and the models displayed rhythmic cycles of blastocoel cavity inflation and deflation reminiscent of living blastocysts.

What followed is arguably the most striking part of the study. Under conditions supporting continuous ex utero development, the ciTotiSC-derived embryo models, or ciToti-EMs, progressed through peri-implantation stages, forming egg cylinder-shaped structures with a pro-amniotic cavity enclosed by SOX2-positive epiblast cells showing apical F-actin and ZO-1 enrichment, precisely as in natural embryos. The models then segregated their embryonic and extraembryonic compartments, developed visceral endoderm and parietal endoderm, and initiated gastrulation, marked by the appearance of Brachyury- and FOXA2-positive cells at a primitive streak. By the equivalent of embryonic day 8.5, the models displayed an anterior-posterior axis, neural folds expressing PAX6, somites marked by HOXB4, a hindgut, and regional specification along both the anterior-posterior and dorsal-ventral axes.

The extraembryonic lineages, often the weak point of synthetic embryo models, were also faithfully generated. Single-cell transcriptomics identified amnion, allantois, yolk sac and parietal endoderm populations in the day-8.5-equivalent models, and Pearson correlation analysis showed transcriptome-wide similarity between these compartments and their natural counterparts. Primordial germ cells emerged as well, identified by co-expression of BLIMP1 and STELLA, and could be tracked migrating through the tail bud and hindgut regions of the models. When dissociated and expanded on feeder layers, these cells showed the epigenetic reprogramming characteristic of the germline, including reduced H3K9me2 and elevated H3K27me3, and progressed toward maturation markers such as DAZL and DDX4. This suggests the ciToti-EM system could become a scalable source of germline cells for studying fertility and heredity.

Blood formation, another milestone of mid-gestation development, proceeded with remarkable fidelity. The models generated vascular endothelium, erythroblasts, hematopoietic epithelia and macrophage populations that clustered alongside their natural E8.5 equivalents in integrated single-cell analyses. Erythroblasts collected from the models were nucleated, as expected for primitive mouse blood, and colony-forming unit assays confirmed that the models contained functional hematopoietic progenitors capable of generating erythroid and macrophage colonies in vitro. The supervised comparison framework the team built, which trains a logistic regression classifier on an annotated atlas of natural embryo data and scores how well each model’s cell types match reference lineages, placed the ciToti-EMs ahead of previously published embryo models across most lineages and stages examined.

Perhaps the most visually compelling result came from extended culture. The ciToti-EMs developed beating heart-like structures, and live imaging captured peristaltic-like contractions in earlier models followed by coordinated, chamber-specific rhythmic beating in later ones. Histological and immunofluorescent analyses of the cardiac tissue revealed a thin epicardial layer, trabeculated myocardium, and regionalized expression of atrial, ventricular and atrioventricular canal markers, closely mirroring natural E10.5 hearts. Single-cell profiling distinguished first heart field, second heart field, atrial and ventricular cardiomyocytes, outflow tract cells, cardiac neural crest cells and endothelial cells, and even identified macrophages and erythroblasts within the cardiac chambers, as seen in natural embryos at this stage.

The implications reach well beyond mouse developmental biology. A model built entirely from a single, chemically induced cell type sidesteps the ethical and practical constraints of using natural embryos or mixtures of multiple stem cell lines, and offers a reproducible, scalable platform for dissecting the molecular logic of early mammalian development. Because the entire process begins with small molecules rather than genetic manipulation, it also hints at a future in which multicellular organisms, or at least substantial portions of them, could be generated from ordinary somatic cells without ever passing through a fertilized egg. The authors are careful to frame the work as a model system, and the models, while extraordinarily complete, are not viable organisms. Nonetheless, the demonstration that one induced cell type can autonomously recapitulate the full spectrum of early mouse embryogenesis marks a watershed for synthetic embryology.

Significant questions remain. The efficiency of progressing from starting aggregates to late-stage models is still modest, and the extrapolated developmental efficiencies suggest substantial attrition at each transition. Whether the same chemical strategy can be adapted to human cells, and what regulatory frameworks should govern such models, are debates that will intensify. For now, the ciToti-EM system gives researchers something they have long lacked: a self-contained, tractable window into mammalian development from the two-cell state to the beating heart, one that can be perturbed, imaged and sequenced at every step. As embryo models grow ever more faithful, the line between modeling life and initiating it grows thinner, and this study moves that line decisively forward.

Subject of Research: Modelling mouse embryogenesis from chemically induced totipotent stem cells

Article Title: Modelling mouse embryogenesis from chemically induced totipotent stem cells

Article References: Modelling mouse embryogenesis from chemically induced totipotent stem cells. (n.d.). https://doi.org/10.1038/s41586-026-11164-5

Image Credits: AI Generated

DOI: 10.1038/s41586-026-11164-5

Keywords: totipotent stem cells, embryo models, mouse embryogenesis, gastrulation, synthetic embryos, ciTotiSCs, blastocyst, cardiogenesis, hematopoiesis, primordial germ cells, single-cell RNA sequencing, developmental biology

The research, led by Chenxi Li, Yingying Qin and Yajuan Yang of Shandong University and collaborating institutions in China, focused on what happens when mouse primordial germ cells lose RAD54 like, or RAD54L. The team found that without this factor, the cells proliferate poorly, leaving an insufficient pool of germ cells and ultimately impairing fertility. The defect traces back to a specific molecular hazard: the accumulation of topoisomerase I cleavage complexes, abbreviated TOP1ccs, which are among the most common and most dangerous lesions that arise during DNA replication.

To appreciate why TOP1ccs matter, it helps to understand what topoisomerase I normally does. As the two strands of the double helix are prised apart for copying, the DNA ahead of the replication machinery becomes overwound, like a rope twisted too tightly. Topoisomerase I relieves this torsional stress by nicking one strand of the DNA, allowing it to swivel freely, and then sealing the break again. The enzyme normally completes this cut-and-paste cycle in a fraction of a second. Occasionally, however, the enzyme becomes trapped mid-cycle, covalently bonded to the DNA at the nick it just created. That trapped enzyme-DNA adduct is the TOP1 cleavage complex, and if it is not removed promptly, the approaching replication fork collides with it, converting a transient intermediate into a double-strand break and stalling DNA synthesis.

Cells possess dedicated machinery to clear these protein-DNA adducts, and the new study adds a surprising player to that list. The researchers showed that RAD54L promotes the degradation of TOP1ccs through the ubiquitin-proteasome pathway, the cellular recycling system that tags unwanted proteins with chains of ubiquitin and delivers them to the proteasome for destruction. The key to this activity lies in a partnership between RAD54L and tripartite motif-containing protein 21, or TRIM21, which the authors identify as a newly recognized E3 ubiquitin ligase responsible for clearing TOP1ccs. E3 ligases are the enzymes that confer specificity on the ubiquitin system, deciding which targets get marked for degradation. In this case, TRIM21 appears to be the enzyme that flags trapped topoisomerase I for removal.

The mechanistic twist is that RAD54L does not itself ligate ubiquitin. Instead, it interacts with TRIM21 and stabilizes the protein, keeping sufficient TRIM21 available to do its clearing work. When RAD54L is absent, TRIM21 is not maintained properly, TOP1ccs accumulate, and the resulting DNA damage escalates. In RAD54L-deficient primordial germ cells, this cascade of events exacerbates DNA damage, undermines proliferation and erodes the reproductive reserve. The finding reframes RAD54L, historically viewed as a homologous recombination factor that helps search for and invade homologous DNA templates during double-strand break repair, as also acting upstream of repair, at the stage of removing the lesions that would otherwise create breaks in the first place.

Primordial germ cells are an especially revealing setting for this kind of analysis. These cells undergo rapid mitotic divisions during embryonic development, and their genome must be transmitted faithfully across generations. High levels of replication, combined with the metabolic demands of a growing embryo, make TOP1ccs a constant threat. The DNA damage response mechanisms that protect somatic cells have been studied extensively, but the regulatory networks that safeguard the germline during this early mitotic phase have remained largely unexplored. By showing that a defect in a single DNA damage response factor can compromise the founding population of the germline, the study connects genome maintenance at the molecular level to fertility at the organismal level.

The experimental logic of the work follows a path familiar to genome stability researchers but with distinctive results. Mice lacking RAD54L in their germ cells show proliferation defects in the primordial germ cell population. The DNA damage observed in these cells is not random; it is specifically tied to TOP1cc accumulation, which means the damage is preventable if the trapped complexes are cleared. The demonstration that RAD54L stabilizes TRIM21 provides a coherent causal chain: loss of RAD54L destabilizes the E3 ligase, the ligase can no longer ubiquitinate trapped topoisomerase I efficiently, the adducts persist, replication forks collide with them, and DNA damage mounts until cells falter or die.

The discovery also resonates with a broader and clinically important theme in cancer medicine. Drugs called topoisomerase I poisons, including camptothecin and its clinical derivatives irinotecan and topotecan, work precisely by stabilizing the TOP1 cleavage complex, trapping the enzyme on DNA and forcing tumor cells into lethal collisions between replication forks and the drug-stabilized adducts. Understanding how healthy cells, and particularly vulnerable populations like germ cells, clear TOP1ccs has implications for how such treatments affect fertility and for how resistance to these drugs emerges. A pathway involving RAD54L and TRIM21 that governs the lifespan of TOP1ccs could, in principle, influence both the toxicity and the efficacy of these widely used chemotherapeutics, although the new study addresses physiology rather than treatment outcomes.

TRIM21 itself carries an interesting scientific history. Long studied in immunology as an antibody receptor inside cells, it has more recently been appreciated as a versatile quality-control factor that recognizes and ubiquitinates a range of intracellular targets. Its identification here as the E3 ligase for TOP1cc clearance in germ cells extends that repertoire into genome maintenance and adds a new dimension to how the ubiquitin system participates in the DNA damage response. The RAD54L-TRIM21 axis suggests that repair factors may do more than mend breaks after they occur; some may actively manage the burden of endogenous lesions so that breaks are less likely to arise at all.

For the field of reproductive biology, the study fills in a piece of a larger puzzle: how the mitotic phase of gametogenesis, before meiosis begins, is protected against the wear and tear of rapid proliferation. The authors frame their results as extending understanding of the regulatory mechanisms that safeguard genome integrity during this process, and the practical significance is clear. A diminished primordial germ cell pool is a diminished reproductive reserve, and the work points to TOP1cc accumulation as one preventable driver of that loss. As with any mouse study, translating the findings to human fertility will require further work, but the core machinery of topoisomerase I, the ubiquitin-proteasome system and the DNA damage response is conserved across mammals, making the pathway a plausible target for future investigations into reproductive health and the side effects of topoisomerase-targeting therapies.

Subject of Research: The role of RAD54L and TRIM21 in clearing topoisomerase I cleavage complexes to maintain genome stability in primordial germ cells

Article Title: RAD54L counteracts topoisomerase I cleavage complexes by stabilizing E3 ligase TRIM21 to maintain genome stability

Article References: Li, C., Wang, S., Xu, W., Kong, Z., Wen, C., Zhao, S., Cao, L., Chen, Z.-J., Zhao, S., Qin, Y., & Yang, Y. (2026). RAD54L counteracts topoisomerase I cleavage complexes by stabilizing E3 ligase TRIM21 to maintain genome stability. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06458-w

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06458-w

Keywords: RAD54L, TRIM21, topoisomerase I cleavage complexes, primordial germ cells, genome stability, DNA damage response, ubiquitin-proteasome pathway, replication stress, fertility, gametogenesis, E3 ubiquitin ligase, DNA repair